Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
Publishing timestamp: 2024-04-04 10:27:47
Summary
Danone's CEO downplays the threat of obesity drugs on its food business, stating that the demand for such drugs will actually increase consumer appetite for nutritional products. Analysts believe concerns over the impact of these drugs on the consumer goods market may be overblown, with companies like Danone and Nestle potentially benefiting in the new landscape.
Sentiment: NEUTRAL
Tickers: BN-FR, NOVO.B-DK, NOVC-FF,
Keywords: danone sa, novo nordisk a/s, health care industry, food and drink, business, business news,